Intensive or conventional insulin therapy in type 2 diabetic patients? A population-based study on metabolic control and quality of life (The JEVIN-trial)

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 8, 1999, Pages 506-511

  Schiel, Ralf ^a,b   Muller U A ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Department of Internal Medicine II   (United States)

Author keywords

Acute and long term complications; Conventional insulin therapy; HbAlc; Intensified insulin therapy; Population based study; Type 2 diabetic patients

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; DIABETES CONTROL; DIABETIC COMA; DISEASE COURSE; EDUCATION; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIOECONOMICS; TREATMENT INDICATION;

EID: 0345073142     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1232559     Document Type: Article

References (36)

1. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS and the VA CSDM Group. Veterans affairs cooperative study on glycemic control and complications in type II diabetes. Diab Care 1995; 18: 1113-23.
2. Alberti KGMM, Gries FA, Jervell J, Krans HMJ for the European NIDDM Policy Group. A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): An update. Diab Med 1994; 11: 899-909.
3. Berger M, Bott U, Grüßer M, Jörgens V, Kronsbein P, Mühlhauser I, Scholz V, Venhaus A, Standl E. Behandlungs-und Schulungs-programm für Typ-II-Diabetiker, die Insulin spritzen. Cologne: Deutscher Ärzte-Verlag, 1990.
4. Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from response of people with tablet-treated diabetes. Diab Med 1990; 7: 445-51.
5. Bradley C, ed. Handbook of psychology and diabetes. Chur: Harwood Academic Publishers, 1994.
6. Bradley C, Gamsu DS for the Psychological Well-being Working Group of the WHO/IDF St. Vincent Declaration Action Programme for Diabetes: Guidelines for encouraging psychological well-being. Report of a working group of the World Health Organization Regional Office for Europe and Internationa Diabetes Federation Euopean Region St. Vincent Declaration action programme for diabetes. Diab Med 1994; 11: 510-6.
7. Brinchmann-Hansen O, Dahl-Jörgensen K, Sandvik L, Hanssen KF. Blood glucose concentrations and progression of diabetic retinopathy: The seven years results of the Oslo study. Br Med J 1992; 304: 19-22.
8. Colwell JA. The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on glycemic control and complications in NIDDM. Ann Int Med 1996; 124: 131-5.
9. Dahl-Jörgensen K, Hanssen KF, Kierulf P, Björo T, Sandvik L, Aagenaes Ö. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus: The Oslo study. Acta Endocrin 1988;117: 19-25.
10. Donohue RP, Orchard TJ. Diabetes mellitus and vascular complications: an epidemiologica perspective. Diab Care 1992; 15: 1141-55.
11. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy with insulin-dependent diabetes. Lancet 1986; II: 1300-4.
12. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T: Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: An update of the Steno studies. Diabetologia 1991; 34: 164-70.
13. Holman RR, Mayon-White V, Orde-Peckar C et al. Prevention of deterioration of renal and sensory nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomized prospective study. Lancet 1983; I: 204-8.
14. Janz H, Müller UA, Pohle B, Rauchfuß J. Wie sinnvoll ist die Blutglukose-Selbstkontrolle bei älteren, insulinpflichtigen Patienten mit Typ-II-Diabetes? (Abstract) Diab Stoffw 1995; 4: 162.
15. Kohner E, Porta M. Screening for diabetic retinopathy in Europe: a field guide-book. Kopenhagen: WHO Regional Office for Europe, 1992.
16. Lewis KS, Bradley C, Knight G, Boulton AJM, Ward JD. A measure of treatment satisfaction designed specially for people with insulin-dependent diabetes. Diab Med 1988; 5: 235-42.
17. Malmberg K for the DIGAMI Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. Br Med J 1997; 314: 1512-5.
18. Mertes B, Franke I, Müller UA, Höffken K, van der Woude FJ. Intensified insulin therapy improved metabolic control without changes of hypoglycemia in 64 insulin treated patients with non insulin dependent diabetes mellitus (NIDDM). (Abstract) Diabetologia 1997; 40: A339.
19. Mühlhauser I, Jörgens V, Berger M, Graninger W, Gurtler W, Hornke L, Kunz A, Schernthaner G, Scholz V, Voss HE. Bicentric evaluation of a teaching programme for type I diabetic patients. Diabetologia 1983; 25: 470-6.
20. Mühlhauser I, Bruckner I, Berger M, Cheta D, Jörgens V, Ionescu-Tirgoviste C, Scholz V, Mincu I. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia 1987; 30: 681-90.
21. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diab Res Clin Pract 1995; 28: 103-17.
22. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): The Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Int Med 191; 230: 101-8.
23. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-9.
24. Reichard P, Pihl M, Rosenqvist U, Sule J: Complications in IDDM are caused by elevated blood glucose level: The Stockholm Diabetes Intervention Study (SDIS) at 10-year follow-up. Diabetologia 1996; 39: 1483-8.
25. Schiel R, Müller UA, Kalbas B, Franke I. Diabeteswissen und Lebensqualität zweier Patientengruppen mit intensivierter konventioneller Insulintherapie. Vier Jahre bzw. unmittelbar nach Teilnahme an einem strukturierten 5-Tage-Behandlungsprogramm. Diab Stoffw 1996; 5: 63-8.
26. Schiel R, Müller UA, Sprott H, Schmelzer A, Mertes B, Hunger-Dathe W, Ross IS. The JEVIN-trial: A population-based survey on the quality of diabetes care in Germany - 1994/95 versus 1989/90. Diabetologia 1997; 40: 1350-7.
27. Schiel R, Müller UA, Janz H, Schmelzer A, Hunger-Dathe W, Mertes B, Ross IS. Änderungen der Behandlungsqualität bei Patienten mit Typ-I-Diabetes 5 Jahre nach Verabschiedung der St. Vincent-Deklaration - Die JEVIN-Studie. Diab Stoffw 1997; 6: 239-44.
28. Schiel R, Müller UA, Ulbrich S. Long-term efficacy of a 5-day structured teaching and treatment programme for intensified conventional insulin therapy and risk for severe hypoglycemia. Diab Res Clin Pract 1997; 35:41-8.
29. Schiel R, Müller UA, Rauchfuß J, Sprott H, Müller R. Blutglucoseselbstkontrollen bei Patienten mit Typ-2-Diabetes mellitus und Insulintherapie - Sinnvoll oder überflüssig? (Abstract) Diab Stoffw 1998; 7: 74-5.
30. Scholz V, Grüßer M, Bott U, Jörgens V. Behandlungs-und Schulungsprogramm für Typ-I-Diabetiker. Mainz: Verlag Kirchheim, 1997.
31. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
32. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications trial. Diabetes 1996; 45: 1289-98.
33. The Kroc Collaborative Study Group: Diabetic retinopathy after two years of intensified insulin treatment. J Am Med Assoc 1988; 260: 37-41.
34. Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD. Mortality in diabetic subjects: An eleven-year follow-up of a community-based population. Diab Med 1994; 11: 968-73.
35. World Health Organization. Diabetes mellitus. Geneva: Technical reports series 727. WHO, 1985.
36. Young MJ, Boulton AJM, Macleod AF, William DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-4.